HARVARD BIOSCIENCE INC (HBIO) SEC News May 12, 2026, 11:30 UTC (99% Positive) HARVARD BIOSCIENCE INC (HBIO) Reports Q2 2026 Financial Results Full text
Register to leave comments News bot May 12, 2026, 11:31 a.m. 📋 HARVARD BIOSCIENCE INC (HBIO) - Financial Results Filing Date: 2026-05-12 Accepted: 2026-05-12 07:30:18 Event Type: Financial Results Event Details: HARVARD BIOSCIENCE INC (HBIO) Reports the reporting period Financial Results HARVARD BIOSCIENCE INC (HBIO) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: 5335 Net Income: $20,755 EPS: Not disclosed Cash and equivalents: (7,098 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2026 2025 Change ($) Change (%) Revenue 20.75K 20.75K $0.00 +0.00% Other Expense Interest Expense 1.73K 1.73K $0.00 +0.00% Other Expense Net Loss 3.42K 3.42K $0.00 +0.00% Liabilities And Stockholders Equity Other Long Term Liabilities 7.82K 7.82K $0.00 +0.00% Cash Flows From Operating Activities Net Loss 3.42K 3.42K $0.00 +0.00% Interest Expense 1.73K 1.73K $0.00 +0.00% Net Loss 3.42K 3.42K $0.00 +0.00% 💼 Business Developments: Partnership: Not availableAcquisitionLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: HARVARD BIOSCIENCE INCTicker Symbol: HBIO
📋 HARVARD BIOSCIENCE INC (HBIO) - Financial Results
Filing Date: 2026-05-12
Accepted: 2026-05-12 07:30:18
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: